JP5601747B2 - Composition for internal use for fatigue prevention and preparation for internal use for fatigue prevention - Google Patents

Composition for internal use for fatigue prevention and preparation for internal use for fatigue prevention Download PDF

Info

Publication number
JP5601747B2
JP5601747B2 JP2006221825A JP2006221825A JP5601747B2 JP 5601747 B2 JP5601747 B2 JP 5601747B2 JP 2006221825 A JP2006221825 A JP 2006221825A JP 2006221825 A JP2006221825 A JP 2006221825A JP 5601747 B2 JP5601747 B2 JP 5601747B2
Authority
JP
Japan
Prior art keywords
fatigue
garlic
composition
internal use
ginseng
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2006221825A
Other languages
Japanese (ja)
Other versions
JP2008044885A (en
Inventor
真也 塚本
哲也 平田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kobayashi Pharmaceutical Co Ltd
Original Assignee
Kobayashi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kobayashi Pharmaceutical Co Ltd filed Critical Kobayashi Pharmaceutical Co Ltd
Priority to JP2006221825A priority Critical patent/JP5601747B2/en
Publication of JP2008044885A publication Critical patent/JP2008044885A/en
Application granted granted Critical
Publication of JP5601747B2 publication Critical patent/JP5601747B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Description

本発明は、生ニンニクを発酵させることによって製造された黒ニンニクと、高麗人参とを有効成分として含有し、疲労予防効果を発揮する疲労予防用内服用組成物に関する。また、本発明は、該疲労予防用内服用組成物を配合した疲労予防用内服用製剤に関する。   The present invention relates to a composition for internal use for fatigue prevention, which contains black garlic produced by fermenting raw garlic and ginseng as active ingredients and exhibits fatigue prevention effects. The present invention also relates to a preparation for internal use for preventing fatigue comprising the composition for internal use for preventing fatigue.

疲労は、生化学成分としてのATPの不足に基づく持続運動能力低下や、乳酸の蓄積による筋肉痛等に関するものであり、物理的な筋肉細胞の損傷又は疲弊に基づくものと、精神的ストレスを意味する疲労感等を総合した抽象語であるとされている。   Fatigue is related to a decrease in sustained motor ability based on the lack of ATP as a biochemical component, muscle pain due to accumulation of lactic acid, etc., which is based on physical muscle cell damage or exhaustion, and means mental stress It is said to be an abstract word that combines fatigue feelings.

抗疲労剤(疲労予防剤)としては、ニンニク、ビタミン類、カフェイン、ローヤルゼリー等を含有する滋養強壮食品又は飲料が従来からあったが、ニンニクについては有効成分であるアリシン等に独特の刺激臭があるため、そのままで内服用として利用することは困難であった。   As anti-fatigue agents (fatigue preventive agents), there have been nourishing tonic foods or beverages containing garlic, vitamins, caffeine, royal jelly, etc., but garlic has a unique stimulating odor for allicin, which is an active ingredient. Therefore, it is difficult to use it as it is.

そこで、生ニンニクを玄米発酵酵素によって発酵させ、摂食時及び食後のニンニク臭を軽減させることが、特許文献1に開示されている。   Therefore, Patent Document 1 discloses that raw garlic is fermented with brown rice fermentation enzyme to reduce the garlic odor during and after eating.

ニンニクの有効成分を強化する方法として、生ニンニクを30℃〜75℃の温度範囲で所定期間温蔵してから取り出して常温に戻し、血栓予防効果を有するシクロアリイン及び/又はS-アリルシステインを高濃度に蓄積し、生理活性を強化した加工ニンニク及びその製造方法が、特許文献2に開示されている。   As a method for strengthening the active ingredient of garlic, raw garlic is stored in a temperature range of 30 ° C. to 75 ° C. for a predetermined period and then taken back to room temperature, and cycloaliin and / or S-allyl cysteine having a thrombus preventing effect is added. Patent Document 2 discloses a processed garlic which is accumulated at a high concentration and has enhanced physiological activity, and a method for producing the same.

また、摂食後の吐息にニンニク臭を発生させない上、生理活性に優れるニンニクとして、生ニンニクを温度55℃〜80℃、湿度70%〜95%の範囲内で熟成させた発酵黒ニンニク及びその製造方法が、特許文献3に開示されている。   In addition, fermented black garlic in which raw garlic is aged within a temperature range of 55 ° C to 80 ° C and a humidity range of 70% to 95% as garlic that does not generate a garlic odor during exhalation after feeding and has excellent physiological activity, and its production A method is disclosed in US Pat.

一方、高麗人参(朝鮮人参)も古来より滋養強壮効果を有する生薬として珍重されてきたが、近年では健康食品等にも利用されている。例えば、特許文献4には高麗人参の薬用成分と、梅実と砂糖から抽出した高糖度梅溶液とを含有する健康飲料が、特許文献4に開示されている。   On the other hand, ginseng (ginseng) has also been prized as a herbal medicine with nourishing and tonic effects since ancient times, but in recent years it has also been used for health foods. For example, Patent Document 4 discloses a health drink containing a ginseng medicinal ingredient and a high sugar content plum solution extracted from plum and sugar.

また、高麗人参抽出物とセルロース加水分解活性及び/又は澱粉加水分解活性を有する微生物又は酵素とを反応させることにより、生理活性成分をそのまま保持しており、甘味剤を添加しなくても爽やかな甘味がある高麗人参糖化甘味食品及びその製造方法が、特許文献5に開示されている。
特開2004−121113号公報 特開2005−278635号公報 特開2006−149325号公報 特開平6−277014号公報 特開平10−14523号公報
In addition, by reacting ginseng extract with a microorganism or enzyme having cellulose hydrolyzing activity and / or starch hydrolyzing activity, the physiologically active ingredient is retained as it is, and it is refreshing without adding a sweetener. A sweet ginseng saccharified sweet food and a method for producing the same are disclosed in Patent Document 5.
JP 2004-121113 A JP 2005-278635 A JP 2006-149325 A JP-A-6-277014 Japanese Patent Laid-Open No. 10-14523

上述したように、ニンニクと高麗ニンジンは、共に滋養強壮効果を有する食材として利用されてきたが、ヒトに対する疲労予防効果は充分には実感できるものとは言い難かった。また、それはニンニク又は高麗人参と、他の滋養強壮効果を有する食材又は生薬を併用した場合についても同様であった。   As described above, both garlic and ginseng have been used as foods having nourishing and tonic effects, but it has been difficult to say that the fatigue prevention effect on humans can be fully realized. Moreover, it was the same when garlic or ginseng was used in combination with other foods or herbal medicines having nourishing tonic effects.

本発明は、ニンニク及び高麗人参の有する滋養強壮効果を相乗的に増大させた疲労予防用内服用組成物、及びそれを配合した疲労予防用内服用製剤の提供を目的とする。   An object of the present invention is to provide a composition for internal use for fatigue prevention in which the nourishing tonic effect of garlic and ginseng is synergistically increased, and a preparation for internal use for fatigue prevention containing the composition.

本発明者等は鋭意研究した結果、生ニンニクを発酵させて製造した黒ニンニクと、高麗人参とを併用した場合に、特異的に滋養強壮効果(疲労予防効果)が相乗的に発揮されることを見出し、本発明を完成させるに至った。   As a result of diligent research, the inventors of the present invention show that, when black garlic produced by fermenting raw garlic and ginseng are used in combination, the nourishing tonic effect (fatigue prevention effect) is exhibited synergistically. As a result, the present invention has been completed.

具体的に、本発明は、
生ニンニクを発酵させて製造した黒ニンニクの粉末と、高麗人参とを有効成分として含有する疲労予防用内服用組成物に関する。
Specifically, the present invention
A powder of black garlic produced by fermenting raw garlic, related to fatigue prophylactic in dosage composition containing a ginseng as an active ingredient.

ニンニク又は高麗人参を含む健康食品や医薬品等は存在するが、本発明の疲労予防用内服用組成物は、生ニンニクを発酵させて製造した黒ニンニクの粉末と高麗人参との組み合わせであり、通常のニンニクと高麗人参との組み合わせにはない、高い疲労予防効果(滋養強壮効果)を有するものである。 Although there are health foods and pharmaceuticals containing garlic or ginseng, the composition for internal use for fatigue prevention of the present invention is a combination of black garlic powder produced by fermenting raw garlic and ginseng, It has a high fatigue prevention effect (nourishing tonic effect) that is not found in the combination of garlic and ginseng.

黒ニンニクは生ニンニクを自己発酵させて製造した黒ニンニクであることが好ましい。高麗人参と併用した場合、他の種類の黒ニンニクよりも高い疲労予防効果が認められるからである。 Black garlic, have preferably be raw garlic is black garlic produced by self-fermentation. This is because when used in combination with ginseng, a higher fatigue prevention effect is recognized than other types of black garlic.

麗人参は乾燥エキスであることが好ましい。なお、適宜黒ニンニクの粉末及び高麗人参に賦形剤を添加してもよく、適当な溶剤によって液剤としてもよい。 Rei Ko carrots is not preferable to be a dry extract. In addition, an excipient may be added to black garlic powder and ginseng as appropriate, or a liquid may be prepared with an appropriate solvent.

本発明の疲労予防用内服用組成物においては、本発明の効果を損なわない範囲で任意の配合割合とする事ができるが、黒ニンニク粉末と高麗人参との配合割合が、重量比で20:1〜1:2であることが好ましい。 In the composition for internal use for preventing fatigue according to the present invention, the blending ratio of black garlic powder and ginseng can be 20% by weight as long as the effect of the present invention is not impaired. 1 to 1: 2 and it is not preferable.

なお、本発明の疲労予防用内服用組成物においては、黒ニンニクの粉末と高麗人参との配合割合が、重量比で15:1〜1:1であることがさらに好ましい。高麗人参の重量配合比が黒ニンニクの粉末の1/15以上では両者の相乗的な疲労予防効果(滋養強壮効果)がより顕著に発揮される。また、黒ニンニクの粉末の重量配合比が高麗人参よりも多い方がより相乗的な疲労予防効果(滋養強壮効果)が発揮される。この場合、高麗人参が非常に高価であるため、組成物の製造コストも抑えられるというメリットもある。 In the composition for internal use for preventing fatigue according to the present invention, the blending ratio of black garlic powder and ginseng is more preferably 15: 1 to 1: 1 by weight. When the weight ratio of ginseng is 1/15 or more of black garlic powder , the synergistic fatigue prevention effect (nourishing tonic effect) of both is more prominent. Further, when the weight ratio of black garlic powder is higher than that of ginseng, a more synergistic fatigue prevention effect (nourishing tonic effect) is exhibited. In this case, since ginseng is very expensive, there is also an advantage that the manufacturing cost of the composition can be suppressed.

本発明の疲労予防用内服用組成物は、1日当たりの経口投与量が0.3mg/体重kg以上400mg/体重kg以下であることが好ましい。黒ニンニクの最大許容摂取量は健常人で15g/日程度と考えられ、高麗人参の最大許容摂取量は5g/日程度と考えられる。すなわち、両者併せて20g/日となり、健常人の体重を50kgと仮定すると400mg/体重kgとなる。 Fatigue prophylactic in dose composition of the present invention, it is not preferable oral dose per day is less than 0.3 mg / kg body weight or higher 400 mg / body weight kg. The maximum allowable intake of black garlic is considered to be about 15 g / day for healthy individuals, and the maximum allowable intake for ginseng is considered to be about 5 g / day. That is, the combined amount is 20 g / day, and assuming that the weight of a healthy person is 50 kg, 400 mg / kg body weight.

また、1日当たり15mg程度以上本発明の疲労予防用内服用組成物を摂食することで、本発明でいう疲労予防効果(滋養強壮効果)がより顕著に現れ始める。健常人の体重を50kgと仮定すると0.3mg/体重kgとなる。   Further, by eating the composition for internal use for preventing fatigue of the present invention of about 15 mg or more per day, the fatigue preventive effect (nutrition tonic effect) referred to in the present invention starts to appear more prominently. Assuming that the weight of a healthy person is 50 kg, it is 0.3 mg / kg body weight.

従って、本発明の疲労予防用内服用組成物の1日当たりの経口投与量は、0.3mg/体重kg以上400mg/体重kg以下とすることが好ましい。なお、長期服用時の有効性及び安全性、並びに高麗人参のコストを考慮すると、1日当たりの経口投与量は、6.6mg/体重kg以上140mg/体重kg以下であることがより好ましい。   Therefore, the daily oral dose of the composition for internal use for preventing fatigue according to the present invention is preferably 0.3 mg / kg to 400 mg / kg of body weight. In consideration of the efficacy and safety when taking for a long time, and the cost of ginseng, the daily oral dose is more preferably 6.6 mg / kg to 140 mg / kg of body weight.

本発明の内服用組成物は、機能性食品として使用できるほか、医薬部外品、飲食物等の成分、食品添加物等としても使用することができる。なお、本発明の内服用組成物には、機能性飲料等の液体飲料も含まれる。   The composition for internal use of the present invention can be used as a functional food, and can also be used as a quasi-drug, a component of food and drink, a food additive, and the like. In addition, liquid drinks, such as a functional drink, are also contained in the composition for internal use of this invention.

また、本発明は、
請求項1乃至5のいずれか1項に記載された疲労予防用内服用組成物を配合した疲労予防用内服用製剤に関する。
The present invention also provides:
About the claim 1 to fatigue prophylactic in dosing formulations containing a combination according fatigue prophylactic in taking the composition in any one of 5.

本発明の疲労予防用内服用製剤の剤形は、カプセル剤、錠剤、散剤、顆粒剤、丸剤又はドリンク剤であることが好ましい。なお、適宜溶剤、賦形剤、崩壊剤、滑沢剤等の添加剤を使用してもよい。 Dosage forms fatigue prophylactic in taking formulations of the present invention include capsules, tablets, powders, granules, it is not preferable is pills or drinks. In addition, additives such as a solvent, an excipient, a disintegrant, and a lubricant may be used as appropriate.

なお、本発明の疲労予防用内服用製剤の例としては、機能性食品、健康食品、一般食品(ジュース、菓子、加工食品等)、栄養補助食品(栄養ドリンク等)等が含まれ、特に健康食品又は医薬品とすることが好ましい。   Examples of internal preparations for preventing fatigue according to the present invention include functional foods, health foods, general foods (juices, confectionery, processed foods, etc.), dietary supplements (nutrition drinks, etc.), etc. It is preferable to use food or medicine.

本発明の疲労予防用内服用組成物及び疲労予防用内服用製剤は、従来のニンニク又は高麗人参が発揮し得なかったヒトに対する疲労予防効果(滋養強壮効果)を有するため、ヒトに対する疲労予防効果(滋養強壮効果)を充分に実感できる。   The composition for internal use for preventing fatigue and the preparation for internal use for preventing fatigue according to the present invention have an anti-fatigue effect (nourished tonic effect) for humans, which cannot be exhibited by conventional garlic or ginseng, and therefore an anti-fatigue effect for humans You can fully experience (nourishing tonic effect).

以下、本発明の実施の形態について説明する。なお、本発明は下記に限定されるものではない。   Embodiments of the present invention will be described below. The present invention is not limited to the following.

(白ニンニク粉末の調整)
市販ニンニク(生ニンニク)の鱗片を、乾燥機(黒田工業製ST-15AS)によって40℃〜65℃の温度範囲で乾燥し、水分率4%の乾燥ニンニクとした。この乾燥ニンニクを、粗粉砕器(増幸産業製MKCM-3)によって粉砕し、さらに高速粉砕器(増幸産業製3M-7-40)によって100meshパスの微粉末とした。この微粉末を白ニンニク粉末と呼ぶ。
(Adjustment of white garlic powder)
The scale of commercially available garlic (raw garlic) was dried in a temperature range of 40 ° C. to 65 ° C. by a dryer (ST-15AS manufactured by Kuroda Kogyo Co., Ltd.) to obtain dried garlic having a moisture content of 4%. The dried garlic was pulverized by a coarse pulverizer (MKCM-3, manufactured by Masuko Sangyo), and further made into a fine powder of 100 mesh pass by a high-speed pulverizer (3M-7-40 manufactured by Masuko Sangyo). This fine powder is called white garlic powder.

(黒ニンニク粉末の調整)
市販ニンニク(生ニンニク)を玄米発酵素によって発酵させた黒ニンニク(三健総合研究所製、黒ニンニク)とした。この黒ニンニクの鱗片を、上記と同様の方法で乾燥及び粉砕し、微粉末とした。この微粉末を黒ニンニク粉末Sと呼ぶ。
(Adjustment of black garlic powder)
Black garlic (manufactured by Sanken Research Institute, black garlic) obtained by fermenting commercially available garlic (raw garlic) with brown rice-derived enzyme. The black garlic scale pieces were dried and pulverized in the same manner as described above to obtain a fine powder. This fine powder is called black garlic powder S.

また、市販ニンニク(生ニンニク)を自己発酵させて製造した発酵黒ニンニク(日新蜂蜜製、醗酵黒ニンニクパウダー)を、上記と同様の方法で粉砕し、微粉末とした。この微粉末を黒ニンニク粉末Aと呼ぶ。   Moreover, fermented black garlic (manufactured by Nissin Honey, fermented black garlic powder) produced by self-fermenting commercially available garlic (raw garlic) was pulverized in the same manner as described above to obtain a fine powder. This fine powder is called black garlic powder A.

(予備的検討)
ニンニクの有する疲労予防効果(滋養強壮効果)を確認するため、ラットに上記白ニンニク粉末及び黒ニンニク粉末を経口投与し、疲労予防効果(滋養強壮効果)を比較検討した。
(Preliminary examination)
In order to confirm the fatigue prevention effect (nutrition tonic effect) of garlic, the above white garlic powder and black garlic powder were orally administered to rats, and the fatigue prevention effect (nutrition tonic effect) was compared.

まず、Wister系雄性ラット(4週齢、体重165〜183g)を体重の平均値が各群等しくなるように10匹ずつ3群に分けた。そして、白ニンニク粉末又は黒ニンニク粉末Sを、毎日定時に胃ゾンデを用いて強制的に摂食させた(各群1日当たり5g/体重kg)。対照群にはこれらは摂食させなかった。なお、3群とも給餌は普通飼料MF(オリエンタル酵母製)を使用し、水と共に自由摂取させた。   First, Wister male rats (4 weeks old, body weight 165 to 183 g) were divided into 3 groups of 10 animals so that the average body weight was equal in each group. Then, white garlic powder or black garlic powder S was forcibly fed using a gastric sonde at a fixed time every day (5 g / kg of body weight per day for each group). These were not fed to the control group. All groups were fed with normal feed MF (Oriental Yeast) and fed freely with water.

摂食開始から隔日に、強制的摂食前にラット運動試験器(中国医学科学院薬物研究所製DXP-2)の毎分80回転させたローターに1匹ずつ乗せ、ローターから落下するまでの持続時間を測定した。その結果を、図1に示す。   Every other day from the start of feeding, the time it takes to ride one rat on the rotor of rat exercise tester (DXP-2, manufactured by the Chinese Institute of Medical Science, DXP-2) before forced feeding, and then drop from the rotor Was measured. The result is shown in FIG.

対照群と比較すると白ニンニク粉末及び黒ニンニク粉末Sを摂食させた群は、運動持続時間が有意に延長し、疲労予防効果(滋養強壮効果)があることが確認できた。一般に黒ニンニクは白ニンニクよりも栄養価が高いとされているが、今回の実験からは、白ニンニク粉末と黒ニンニク粉末との間に疲労予防効果(滋養強壮効果)に差が認められなかった。   Compared with the control group, it was confirmed that the group fed with white garlic powder and black garlic powder S significantly prolonged exercise duration and had a fatigue prevention effect (nutrition tonic effect). In general, black garlic is said to have higher nutritional value than white garlic, but from this experiment, there was no difference in fatigue prevention effect (nourishing tonic effect) between white garlic powder and black garlic powder. .

(疲労予防用内服カプセルの調整)
以下に示す5種類のカプセル製剤を製造し、ヒトに対する疲労予防効果(滋養強壮効果)を比較検討した。
(Adjustment of internal capsule for fatigue prevention)
The following five types of capsule preparations were manufactured, and the fatigue prevention effect (nourishing tonic effect) on humans was compared and examined.

[比較例1]
有効成分として高麗人参乾燥エキス(インデナ社製、ニンジンカンソウエキス)3.3重量%、調整剤としてチアミン硫酸塩0.1重量%、サフラワーサラダ油82.6%、グリセリン脂肪酸エステル6重量%、ミツロウ6重量%及び大豆レシチン2重量%を配合した溶液を調製した。その溶液300mgをゼラチン、グリセリン及びフィチン酸によって被膜組成したソフトカプセルに充填し、比較例1のカプセル製剤とした。
[Comparative Example 1]
Ginseng dry extract (Indena, carrot licorice extract) 3.3% by weight as active ingredients, Thiamine sulfate 0.1% by weight, safflower salad oil 82.6%, glycerin fatty acid ester 6% by weight, beeswax 6% by weight and soybean lecithin A solution containing 2% by weight was prepared. 300 mg of the solution was filled into soft capsules coated with gelatin, glycerin and phytic acid to give a capsule preparation of Comparative Example 1.

[比較例2]
有効成分として白ニンニク粉末33.4重量%及び高麗人参乾燥エキス(インデナ社製、ニンジンカンソウエキス)3.3重量%、調整剤としてチアミン硫酸塩0.1重量%、サフラワーサラダ油49.2%、グリセリン脂肪酸エステル6重量%、ミツロウ6重量%及び大豆レシチン2重量%を配合した溶液を調製した。その溶液300mgを比較例1と同様、ソフトカプセルに充填し、比較例2のカプセル製剤とした。
[Comparative Example 2]
White garlic powder as active ingredient 33.4% by weight and ginseng dried extract (manufactured by Indena, carrot ginseng extract) 3.3% by weight, thiamin sulfate 0.1% by weight, safflower salad oil 49.2%, glycerin fatty acid ester 6% by weight, A solution containing 6% by weight of beeswax and 2% by weight of soybean lecithin was prepared. As in Comparative Example 1, 300 mg of the solution was filled into soft capsules to obtain a capsule preparation of Comparative Example 2.

[実施例1]
白ニンニク粉末の代わりに黒ニンニク粉末Sを使用すること以外、すべて比較例2と同様にしてカプセル製剤を製造した。
[Example 1]
A capsule preparation was produced in the same manner as in Comparative Example 2 except that black garlic powder S was used instead of white garlic powder.

[実施例2]
白ニンニク粉末の代わりに黒ニンニク粉末Aを使用すること以外、すべて比較例2と同様にしてカプセル製剤を製造した。
[Example 2]
A capsule preparation was produced in the same manner as in Comparative Example 2 except that black garlic powder A was used instead of white garlic powder.

[対照例]
チアミン硫酸塩0.1重量%、サフラワーサラダ油85.9%、グリセリン脂肪酸エステル6重量%、ミツロウ6重量%及び大豆レシチン2重量%を配合した溶液を調製した。この溶液を比較例と同様、ソフトカプセルに充填し、対照例のカプセル製剤とした。
[Control example]
A solution containing 0.1% by weight thiamine sulfate, 85.9% safflower salad oil, 6% by weight glycerin fatty acid ester, 6% by weight beeswax and 2% by weight soy lecithin was prepared. As in the comparative example, this solution was filled into soft capsules to obtain a capsule preparation of a control example.

(モニタリング試験)
健常男性をモニターとして5群に分け、上記5種類のカプセル製剤を各群1日3粒として2日間内服させた。そして、通常の生活をし、普段と比較して飲用開始2日後の「疲労予防効果(滋養強壮効果)」について、5段階(はっきりある、ある、少しある、あまりない、ない)で評価させた。各段階について、はっきりある:10点、ある:7.5点、少しある:5点、あまりない:2.5点、ない:0点として数値化し、平均値を算出した。その結果を、表1に示す。なお、比較例1及び比較例2は5人、それ以外は4人のモニターによる評価である。
(Monitoring test)
Healthy men were divided into 5 groups as a monitor, and the above 5 kinds of capsule preparations were taken orally for 3 days, 3 tablets per group. And, in a normal life, compared to the usual, “fatigue prevention effect (nourishing tonic effect)” 2 days after the start of drinking was evaluated in five levels (clear, some, some, not so much, no) . For each stage, there was a clear: 10 points, there was: 7.5 points, there was a little: 5 points, not so much: 2.5 points, not: 0 points, and the average value was calculated. The results are shown in Table 1. In addition, Comparative Example 1 and Comparative Example 2 are evaluated by a monitor of 5 persons, and the others are evaluated by 4 persons.

Figure 0005601747
Figure 0005601747

まず、対照例のカプセル製剤には、疲労予防効果(滋養強壮効果)を有する成分が本来含まれていないが、プラセボ効果が現れたモニターが半数いた。   First, the capsule preparation of the control example does not originally contain a component having a fatigue prevention effect (nutrition tonic effect), but half of the monitors that exhibited a placebo effect.

次に、疲労予防効果(滋養強壮効果)を有する成分として高麗人参エキスを含む比較例1のカプセル製剤は、対照例よりも低い平均値となった。また、白ニンニク粉末及び高麗人参エキスを含む比較例2のカプセル製剤は、対照例及び比較例1よりも平均値が高かったが、10点満点の5点には到達しなかった。   Next, the capsule formulation of Comparative Example 1 containing ginseng extract as a component having a fatigue prevention effect (nutrition tonic effect) had a lower average value than the control example. In addition, the capsule preparation of Comparative Example 2 containing white garlic powder and ginseng extract had a higher average value than the control example and Comparative Example 1, but did not reach 5 points out of 10 points.

これらに対して、黒ニンニクS又は黒ニンニクAと高麗人参エキスとを含む実施例1及び実施例2のカプセル製剤は平均値が5点を超え、比較例2よりも強い疲労予防効果(滋養強壮効果)が確認された。特に、実施例2のカプセル製剤は、4人のモニター全員が疲労予防効果(滋養強壮効果)を感じていた。   In contrast, the capsule preparations of Example 1 and Example 2 containing black garlic S or black garlic A and ginseng extract have an average value of more than 5 points, and have a stronger fatigue prevention effect (nutrition tonic) Effect) was confirmed. In particular, in the capsule preparation of Example 2, all four monitors felt a fatigue prevention effect (nourishing tonic effect).

予備的試験では、白ニンニク粉末と黒ニンニク粉末の間では疲労予防効果(滋養強壮効果)に差が認められなかったが、本発明の疲労予防用内服用製剤は、黒ニンニクと高麗人参とを組み合わせることにより、白ニンニク、高麗人参及びこれらの組み合わせにはない優れた疲労予防効果(滋養強壮効果)を有することが確認された。   In a preliminary test, there was no difference in fatigue prevention effect (nourishing tonic effect) between white garlic powder and black garlic powder. However, the internal preparation for fatigue prevention of the present invention contains black garlic and ginseng. By combining, it was confirmed that white garlic, ginseng and excellent anti-fatigue effect (nourishing tonic effect) not found in these combinations.

本発明の疲労予防用内服用組成物及び疲労予防用内服用製剤は、健康食品分野又は医薬品分野において有用である。   The composition for internal use for preventing fatigue and the preparation for internal use for preventing fatigue of the present invention are useful in the field of health foods or pharmaceuticals.

予備的検討の実験結果を表すグラフである。It is a graph showing the experimental result of preliminary examination.

Claims (7)

生ニンニクを発酵させて製造した黒ニンニクの粉末と、高麗人参とを有効成分として含有する疲労予防用内服用組成物。 A composition for internal use for preventing fatigue, comprising black garlic powder produced by fermenting raw garlic and ginseng as active ingredients. 黒ニンニクが生ニンニクを自己発酵させて製造した黒ニンニクである請求項1に記載の疲労予防用内服用組成物。   The composition for internal use for fatigue prevention according to claim 1, wherein the black garlic is black garlic produced by self-fermenting raw garlic. 麗人参が乾燥エキスである請求項1又は2に記載の疲労予防内服用組成物。 Fatigue prevention in dose composition according to claim 1 or 2 Rei Ko ginseng is dried extract. 黒ニンニクの粉末と高麗人参との配合比率が、重量比で20:1〜1:2である請求項1乃至3のいずれか1項に記載の疲労予防用内服用組成物。 The composition for internal use for fatigue prevention according to any one of claims 1 to 3, wherein a blending ratio between the powder of black garlic and ginseng is 20: 1 to 1: 2. 1日当たりの経口投与量が0.3mg/体重kg以上400mg/体重kg以下である請求項1乃至4のいずれか1項に記載の疲労予防用内服用組成物。   The composition for internal use for fatigue prevention according to any one of claims 1 to 4, wherein an oral dose per day is 0.3 mg / kg to 400 mg / kg of body weight. 請求項1乃至5のいずれか1項に記載の疲労予防用組成物を配合した疲労予防用内服用製剤。   A preparation for internal use for preventing fatigue, comprising the composition for preventing fatigue according to any one of claims 1 to 5. 剤形がカプセル剤、錠剤、散剤、顆粒剤、丸剤又はドリンク剤である請求項6に記載の疲労予防用内服用製剤。   The internal preparation for fatigue prevention according to claim 6, wherein the dosage form is a capsule, tablet, powder, granule, pill or drink.
JP2006221825A 2006-08-16 2006-08-16 Composition for internal use for fatigue prevention and preparation for internal use for fatigue prevention Active JP5601747B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006221825A JP5601747B2 (en) 2006-08-16 2006-08-16 Composition for internal use for fatigue prevention and preparation for internal use for fatigue prevention

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006221825A JP5601747B2 (en) 2006-08-16 2006-08-16 Composition for internal use for fatigue prevention and preparation for internal use for fatigue prevention

Publications (2)

Publication Number Publication Date
JP2008044885A JP2008044885A (en) 2008-02-28
JP5601747B2 true JP5601747B2 (en) 2014-10-08

Family

ID=39178966

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006221825A Active JP5601747B2 (en) 2006-08-16 2006-08-16 Composition for internal use for fatigue prevention and preparation for internal use for fatigue prevention

Country Status (1)

Country Link
JP (1) JP5601747B2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105146371B (en) * 2015-07-17 2018-11-20 徐州黎明食品有限公司 A kind of black garlic cordyceps sinensis particle and preparation method thereof
KR20180044793A (en) * 2016-10-24 2018-05-03 모모야 컴퍼니 리미티드 Anti-fatigue food composition and anti-fatigue agent
JP7130259B2 (en) * 2020-01-17 2022-09-05 ゆらら株式会社 Female vaginal cleansing/anti-aging/immunity-enhancing agent composition and method for producing the same

Also Published As

Publication number Publication date
JP2008044885A (en) 2008-02-28

Similar Documents

Publication Publication Date Title
US6413545B1 (en) Diet composition and method of weight management
US7932288B2 (en) Composition for relieving subjective symptoms of fatigue
US20180104299A1 (en) Use of saffron and/or safranal and/or crocin and/or picrocrocin and/or derivatives thereof as a satiation agent for the treatment of obesity
TW200843726A (en) Agent for relief or prevention of xerostomia
JP5921664B2 (en) Oral preparation for preventing or improving dry skin
KR101961974B1 (en) Agent for improving quality of sleep
JP4119629B2 (en) Antihypertensive agent
WO2009082883A1 (en) Antiobesity composition
JP2016199491A (en) Mood state improver
JP5601747B2 (en) Composition for internal use for fatigue prevention and preparation for internal use for fatigue prevention
JP2008266223A (en) Formulation for ameliorating excessive sensitivity to cold
KR101721145B1 (en) - Food composition including -Carnitine Magnesium Citrate for diet and promoting bowel movement
KR101910013B1 (en) A composition for improving, preventing and treating of pain comprising herb extract
JP6840647B2 (en) Liquid composition, its cloudiness improving agent, odor improving agent, and manufacturing method
JP4359046B2 (en) Anti-stress agent
KR20160056426A (en) Composition for improving exercise performance and recovering fatigue comprising Gynura procumbens extract
JP2001046017A (en) Health food composition
JP6698034B2 (en) Oral composition for improving systemic symptoms such as chills
JP2020137496A (en) Composition containing mulberry leaf processed product
KR20190014220A (en) Composition of mixed ferment extraction liquid for hangover elimination and hangover eliminator containing composition as effective ingredient thereof
JP2004292355A (en) Anti-stress agent
CN107801830A (en) Teeth oral cavity cleansing tablet without gum with edible
JP4435882B2 (en) Alcohol absorption inhibiting composition
US11278515B2 (en) Composition for improvement of sleep or for prevention or treatment of sleep disorders, containing beta-lapachone
JP4997514B2 (en) Antihypertensive agent

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090629

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120327

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120703

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140613

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20140613

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140819

R150 Certificate of patent or registration of utility model

Ref document number: 5601747

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250